In both cancer and development, CD49f can act as a receptor for laminins, with loss of either laminins or deletion of CD49f leading to alterations in breast cancer cell survival (Goel et al., 2014), cerebral malformations and skin blistering in mice (Georges-Labouesse et al., 1996). Here, ITGA6 is linked to breast carcinoma.